1. Home
  2. AWRE vs PMN Comparison

AWRE vs PMN Comparison

Compare AWRE & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWRE
  • PMN
  • Stock Information
  • Founded
  • AWRE 1986
  • PMN 2004
  • Country
  • AWRE United States
  • PMN Canada
  • Employees
  • AWRE N/A
  • PMN N/A
  • Industry
  • AWRE Computer Software: Prepackaged Software
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • AWRE Technology
  • PMN Health Care
  • Exchange
  • AWRE Nasdaq
  • PMN Nasdaq
  • Market Cap
  • AWRE 35.2M
  • PMN 29.8M
  • IPO Year
  • AWRE 1996
  • PMN N/A
  • Fundamental
  • Price
  • AWRE $1.56
  • PMN $0.82
  • Analyst Decision
  • AWRE
  • PMN
  • Analyst Count
  • AWRE 0
  • PMN 0
  • Target Price
  • AWRE N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • AWRE 43.5K
  • PMN 44.3K
  • Earning Date
  • AWRE 03-05-2025
  • PMN 03-31-2025
  • Dividend Yield
  • AWRE N/A
  • PMN N/A
  • EPS Growth
  • AWRE N/A
  • PMN N/A
  • EPS
  • AWRE N/A
  • PMN N/A
  • Revenue
  • AWRE $16,966,000.00
  • PMN N/A
  • Revenue This Year
  • AWRE $10.98
  • PMN N/A
  • Revenue Next Year
  • AWRE N/A
  • PMN N/A
  • P/E Ratio
  • AWRE N/A
  • PMN N/A
  • Revenue Growth
  • AWRE N/A
  • PMN N/A
  • 52 Week Low
  • AWRE $1.35
  • PMN $0.80
  • 52 Week High
  • AWRE $2.97
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • AWRE 43.90
  • PMN 36.19
  • Support Level
  • AWRE $1.54
  • PMN $0.81
  • Resistance Level
  • AWRE $1.78
  • PMN $0.94
  • Average True Range (ATR)
  • AWRE 0.11
  • PMN 0.07
  • MACD
  • AWRE -0.01
  • PMN -0.01
  • Stochastic Oscillator
  • AWRE 8.33
  • PMN 6.07

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: